Kamran Torbati, MD
Obstetrics & Gynecology · Tarzana, CANPI 1639183056
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,400 of the $8,488 with a category attached, or 63.6%. Mimedx Group, Inc. accounts for 63.6% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $4,680, 8.5 times the $548 reported in 2019. Among obstetrics & gynecology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 173 payments — averaging $49.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$5K
- AbbVie$788
- Therapeuticsmd, Inc.$329
- Celularity Inc.$300
- Hologic Sales And Service, LLC$236
- Pfizer$199
- plus $1K from 20 others
What the payments were for
- Consulting fees$5,40064%
- Speaking & faculty fees$3004%
- Food & beverage$2,74032%
- Education$471%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 15 | $5,400 |
| AbbVie(2 entities) | 60 | $788 |
| Therapeuticsmd, Inc. | 15 | $329 |
| Celularity Inc. | 1 | $300 |
| Hologic Sales And Service, LLC | 9 | $236 |
| Pfizer | 7 | $199 |
| Mayne Pharma Commercial LLC | 8 | $186 |
| Avion Pharmaceuticals | 23 | $174 |
| Coopersurgical, Inc. | 7 | $132 |
| Organon | 1 | $122 |
| Merck | 3 | $93 |
| Sage Therapeutics, LLC | 2 | $56 |
| Bayer | 2 | $55 |
| Sumitomo Pharma America, Inc. | 1 | $51 |
| Lupin Inc. | 4 | $50 |
| AMAG Pharmaceuticals, Inc. | 2 | $47 |
| Scynexis, Inc. | 2 | $42 |
| Exeltis, USA Inc. | 2 | $41 |
| Roche Diagnostics Corporation | 1 | $34 |
| Shield Therapeutics Inc | 2 | $29 |
| Vertical Pharmaceuticals, LLC | 1 | $25 |
| Millicent US Inc | 1 | $24 |
| Agile Therapeutics, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
| Myovant Sciences Inc. | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOVINE COLLAGEN$600
- IMVEXXY$124
How this compares
$8,488 in reported general payments places this provider in the 95th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 137 | $10,497 |
| Estradiol (Twice Weekly)Estradiol | 16 | $1,328 |
| Terconazole | 19 | $538 |
| Solifenacin Succinate | 15 | $516 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $248 |
| Fluconazole | 16 | $46 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Tarzana
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
- Marc WinterLaguna Hills$399K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.